FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Cni Q1: Eps Beats, Revenue Lags, Operational Gains Amid Headwinds

作者

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

CNI posted Q1 adjusted EPS of CAD1.80, topping our CAD1.73 estimate but missing the consensus CAD1.81 forecast. Revenue declined 1% to CAD4.38B, as 3% volume growth was offset by a 3% freight revenue per RTM decline from FX and carbon tax headwinds. The operating ratio deteriorated 80 bps to 64.2%, as cost inflation outpaced revenue growth despite operational improvements including record Q1 fuel efficiency and 8% employee productivity gains. Segment performance was mixed: grain/fertilizers surged 10% while metals/minerals fell 11%, though underlying momentum remained solid with 2% constant currency revenue growth. Management reiterated expectations for flattish RTM growth in FY 26, with EPS growth slightly exceeding volume growth and a continued CAD2.8B capex program. FCF surged 44% to CAD900M, supporting CAD869M in share repurchases. We view the strong operational metrics and cash generation positively, though margin pressure from inflationary costs and FX headwinds remains a near-term concern.

相關文章

Australia

瑞銀表示,星巴克將維持銷售成長勢頭,下半年將聚焦在利潤率。

瑞銀週三在一份報告中指出,星巴克 (SBUX) 有望在其轉型策略的推動下保持強勁的銷售勢頭,但投資者關注的焦點正轉向下半年的利潤率復甦。 瑞銀表示,第二季強勁的交易驅動同店銷售成長反映了營運改善、菜單創新和更新的會員計畫。 展望未來,瑞銀表示,持續推動下午飲品平台、會員計畫升級、門市關閉和營運改善等措施應能支撐下半年的銷售成長。 瑞銀也預計,在銷售槓桿、成本節約以及關稅和咖啡成本壓力緩解的推動下,星巴克的利潤率將在今年稍後有所提升。 瑞銀將星巴克的目標股價從100美元上調至105美元,但維持「中性」評級。Price: $106.10, Change: $+8.82, Percent Change: +9.06%

$SBUX
Australia

美國銀行證券調漲評級後,Elevance Health股價上漲

週三,Elevance Health (ELV) 股價上漲 2.5%,此前美國銀行證券將該股評級從“中性”上調至“買入”,目標價為 435 美元。 成交量約 140 萬股,低於日均 190 萬股以上。Price: $371.74, Change: $+9.00, Percent Change: +2.48%

$ELV
Australia

Wedbush將Biogen的目標股價從191美元上調至196美元,理由是“催化引擎正在加速運轉”,並維持中性評級。

根據FactSet調查的分析師報告,百健(BIIB)的平均評級為“增持”,平均目標價為213.79美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)Price: $195.08, Change: $+11.70, Percent Change: +6.38%

$BIIB